Implantable Glucose Sensor Market Report 2026

Implantable Glucose Sensor Market Overview

• Implantable Glucose Sensor market size has reached to $8.14 billion in 2025 • Expected to grow to $16.05 billion in 2030 at a compound annual growth rate (CAGR) of 14.5% • Growth Driver: Increasing Prevalence Of Diabetes Fueling The Growth Of The Market Due To Increasing Lifestyle-Related Health Risks • Market Trend: Fully Implantable Device Offers Continuous Glucose Monitoring And Alerts • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Implantable Glucose Sensor Market?

An implantable glucose sensor is a small medical device placed under the skin that continuously tracks the body’s glucose levels and sends the readings to an external monitor or smart device. It helps individuals manage diabetes more easily by providing real-time data without frequent finger-prick tests. This device works for an extended period inside the body and offers a more convenient and consistent way to monitor blood sugar. The main product types of implantable glucose sensor are long-term implantable sensors, and short-term implantable sensors. Long-term implantable sensors refer to glucose monitoring devices that are designed to be implanted under the skin for an extended period, typically weeks to months, to continuously measure blood glucose levels. It utilizes technologies such as enzymatic, and non-enzymatic and finds applications in type 1 diabetes, type 2 diabetes, gestational diabetes, serving end-users such as hospitals, clinics, homecare settings, and others.

What Is The Implantable Glucose Sensor Market Growth Forecast?

The implantable glucose sensor market size is expected to see rapid growth in the next few years. It will grow to $16.05 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to growing demand for long term monitoring, integration with insulin delivery systems, expanding diabetic population, technological miniaturization, supportive reimbursement policies. Major trends in the forecast period include long duration implantable monitoring, finger prick free diabetes management, improved biocompatible sensor materials, continuous real time glucose tracking, rising adoption of home based monitoring.

Global Implantable Glucose Sensor Market Segmentation

1) By Product Type: Long-term Implantable Sensors, Short-term Implantable Sensors 2) By Technology: Enzymatic, Non-Enzymatic 3) By Application: Type 1 Diabetes, Type 2 Diabetes 4) By End-User: Hospitals, Clinics, Homecare Settings, Other End-Users Subsegments: 1) By Long-Term Implantable Sensors: Enzyme-Based, Electrochemical, Fluorescence-Based 2) By Short-Term Implantable Sensors: Minimally Invasive, Biocompatible Hydrogel-Based

What Is The Driver Of The Implantable Glucose Sensor Market?

The increasing prevalence of diabetes is expected to propel the growth of the implantable glucose sensor market going forward. Diabetes is a chronic medical condition where the body is unable to properly regulate blood sugar or glucose levels. Diabetes is rising mainly due to unhealthy lifestyles, such as reduced physical activity and increased intake of high-calorie foods, which increases the likelihood of developing type 2 diabetes. Implantable glucose sensors aid in diabetes management by offering continuous and long-term monitoring of blood glucose levels, making them ideal for patients requiring tight glucose control. They reduce the need for frequent finger-prick tests by providing real-time data and alerts, improving overall patient convenience and health outcomes. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing prevalence of diabetes is driving the growth of the implantable glucose sensor industry.

Key Players In The Global Implantable Glucose Sensor Market

Major companies operating in the implantable glucose sensor market are Senseonics Holdings Inc., GlySens Incorporated, Profusa Inc., Abbott Laboratories, Dexcom Inc., Medtronic plc, Biolinq Inc., Nemaura Medical Inc., Integrated Sensing Systems Inc., WaveForm Technologies Inc., BioMems Solutions Inc., Echo Therapeutics Inc., Glucovation Inc., Know Labs Inc., Pacific Diabetes Technologies Inc., Metronom Health Inc., AliveCor Diabetes Inc., Pixelligent Technologies Inc., OrSense Ltd., Medtrum Technologies Inc.

Global Implantable Glucose Sensor Market Trends and Insights

Major companies operating in the implantable glucose sensor market are focusing on developing advanced products, such as long-term implantable sensors, to boost patient convenience, enhance health outcomes, and reduce the frequency of device management. Long-term implantable sensors refer to advanced medical devices that are inserted under the skin to continuously measure glucose levels in the interstitial fluid for extended periods, unlike short-term sensors that require frequent replacement. For instance, in September 2024, Senseonics Holdings Inc., a US-based medical technology company, received approval from the U.S. Food and Drug Administration (FDA) for the Eversense 365 continuous glucose monitoring system for people with Type 1 and Type 2 diabetes aged 18 years and older. It features a fully implantable sensor lasting up to 365 days, providing continuous glucose readings and alerts for high and low glucose levels. It also integrates with a mobile app and cloud-based platform, allowing patients and healthcare providers to track glucose trends and make informed treatment decisions remotely.

What Are Latest Mergers And Acquisitions In The Implantable Glucose Sensor Market?

In May 2024, Senseonics Holdings Inc., a US-based medical technology company, partnered with Mercy. This collaboration aims to expand the clinical use of the Eversense continuous glucose monitoring system across Mercy’s network, enabling patients to benefit from long-duration implantable glucose sensing supported by remote patient monitoring and enhanced endocrinology workflows. Mercy is a US-based integrated health care organization that provides hospital care, outpatient services, virtual care solutions, and chronic disease management programs.

Regional Outlook

North America was the largest region in the implantable glucose sensor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Implantable Glucose Sensor Market?

The implantable glucose sensor market consists of sales of implantable glucose monitoring devices, biocompatible sensor probes, external data transmitters, wearable reader units, calibration accessories, and adhesive patches. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.